Trial Profile
The double blind, placebo controlled trial of modafinil for excessive daytime sleepiness in Parkinson's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Mar 2019
Price :
$35
*
At a glance
- Drugs Modafinil (Primary)
- Indications Hypersomnia
- Focus Therapeutic Use
- 25 Mar 2019 Status changed from recruiting to completed.
- 08 Nov 2017 Status changed from not yet recruiting to recruiting.
- 13 Nov 2015 New trial record